9001 Wilshire Boulevard ♦ Suite 204 ♦ Beverly Hills ♦ CA 90211
Phone 323.957.4700 ♦ info@neurocoglab.com
LICENSE:
Board of Medical Quality Assurance PSY 11042 (First issued 03/01/89)
(Now California Board of Psychology)
BOARD CERTIFICATION:
American Board of Clinical Neuropsychology
American Board of Professional Psychology
CURRENT POSITIONS:
Philip K. Stenquist, Ph.D., ABPP/ABCN
9001 Wilshire Boulevard, Suite 204
Beverly Hills, CA 90211
Phone: 323.957.4700
neurocoglab.com (info@neurocoglab.com)
Associate Clinical Professor of Psychiatry and Biobehavioral Sciences
David Geffen School of Medicine, UCLA
Resnick Neuropsychiatric Hospital
Semel Institute for Neuroscience and Human Behavior, UCLA
760 Westwood Plaza
Los Angeles, CA 90024
Faculty NC 447, Post Doctoral Seminar: Research Methods in Neurocognition
pstenquist@mednet.ucla.edu
Clinical Supervisor: Medical Psychology Assessment Center
HOSPITAL AFFILIATION:
UCLA Center for the Health Sciences
UCLA Resnick Neuropsychiatric Institute and Hospitals
Semel Institute for Neuroscience and Human Behavior
MPAC (Medical Psychology Assessment Center)
760 Westwood Plaza
Los Angeles, California 90024
310.206.8100
EDUCATION:
B.A., 1981 (Honors, Phi Kappa Phi), Psychology [Emphasis in Cognitive Science] College of Science, Florida Atlantic University
Ph.D., 1987 (Honors, Phi Kappa Phi), Clinical Psychology
Adult Track (APA Status: continuous full approval since 1962)
Southern Illinois University at Carbondale
Intern, 1986-87: West Los Angeles Veterans Administration Medical Center
Neurobehavior Unit. Ancillary training provided through the Neuropsychiatric Institute (NPI), UCLA School of Medicine.
Postdoctoral Psychology Assistant, 1988-1989: Neurocognitive Laboratory, Keith Medical Group. Psychology Assistant to Wilfred G. van Gorp, Ph.D., ABCN (then Director of Neuropsychology Training, UCLA Neuropsychiatric Institute).
American Board of Professional Psychology: American Board of Clinical Neuropsychology (ABPP/ABCN #4669) Conferred on 8/10/96. Recertified [MOC] 09/12/17.
PROFESSIONAL ASSOCIATIONS:
American Psychological Association
Society for Clinical Neuropsychology: Division 40
Member of thePracticeAdvisory Committee (1996-1999)
International Neuropsychological Society
Professional Member
National Academy of Neuropsychology
Professional Member
American Academy of Clinical Neuropsychology
Member as Certified by ABCN
TEACHING APPOINTMENTS:
1997-Present
Associate Clinical Professor: Psychiatry and Biobehavioral Sciences
Neuropsychology Post-Doctoral Program (MPAC)
David Geffen School of Medicine, Semel Institute for Neuroscience and Human Behavior
University of California, Los Angeles
Los Angeles, California
1985
Visiting Foreign Lecturer in Behavioral Sciences
The Learning and Technology Centre, Petaling Jaya,
Kuala Lumpur, Malaysia
1982-1984
Instructor: Introductory Psychology and Laboratory Methods in Neuroscience
Southern Illinois University
Carbondale, Illinois
CLINICAL CONSULTATION
Dr. Stenquist has performed over 3000 examinations in over 25 years of clinical practice representing all areas of diagnosis and patient care. His primary involvement for many years in medical care for HIV/AIDS spectrum patients brought him into contact with both focal and diffuse neurological vectors of all varieties, from neoplasms, such as CNS Lymphoma, PML, and Astrocytomas, to infectious conditions, such as Cerebral Toxoplasmosis and Cryptococcal Meningitis, to chronic, degenerative diseases, such as HIV and CMV Encephalopathy. He has also examined numerous patients suffering from Traumatic Brain Injury, cerebrovascular conditions and dementias of aging. Patients have also represented all varieties of psychiatric conditions, including psychosis, affective disorders, anxiety disorders, somatoform disorders and PTSD among others. He is familiar with all major extraneous factors in testing such as malingering, pain and concurrent treatment with analgesic, psychiatric and other medications. He has provided clinical diagnosis in both inpatient and outpatient settings. In 2007 he was invited by Oxford University Press to be among the reviewers of the 4th Edition of Neuropsychological Assessment (Lezak, Howeison & Loring, 2004), in preparation for the next edition of one of the seminal texts in the field of Clinical Neuropsychology. His clinical patients have ranged from Academy Award recipients and household names, to homeless schizophrenics, one memorably presenting with a pilfered street sign as his ‘writing tablet’.
FORENSIC CONSULTATION
Dr. Stenquist has consulted on all neurocognitive and neuroaffective aspects of personal injury, disability, patient veracity and testamentary and contractual capacity. He has been a consultant to individual attorneys as well as large corporations such as Metropolitan Life, Unum Provident, State Farm and Farmer’s Group among others. He has consulted on cases throughout the state of California as well as in Nevada, Colorado, Oklahoma, Nebraska, New York and Alaska. He has been an expert in Federal jurisdictions as well. He has been an expert to counsel for the Los Angeles Kings hockey team and an evaluator for counsel to retired NFL players regarding CTE. He has evaluated psychologist fitness for the Psychology Board of California. He has served as an external evaluator of Physician Fitness for the Kaiser Permanente Medical System. Dr. Stenquist has testified in numerous depositions, arbitrations and mediations. He has provided trial testimony in the California Superior Courts of Los Angeles, Santa Monica, Long Beach, San Jose, Pomona, San Pedro, San Diego, Indio and Orange Counties. He has provided consultation to both plaintiff and defense counsel in all civil forensic settings.
PRESENTATIONS
The Psychological Diagnosis and Management of the HIV Spectrum Patient. Van Nuys Psychiatric Hospital, January 11, 1993.
AIDS Related Neurological Illness: Findings, Theory and Clinical Considerations. Casa Colina Center for Rehabilitation, July 13, 1993.
Clinical Neuropsychology and HIV Infection: A View from the Trenches. UCLA Neuropsychiatric Institute, January 19, 1995.
Neuropsychological Consequences of HIV Infection. Third Annual Conference on Psychopathology, Psychopharmacology, Substance Abuse and Culture, Los Angeles, October 5, 1995.
Neurocognitive Examination in Traumatic Brain Injury: Forensic Considerations. Medex Medical Consultants, Carson, CA, November 9, 1995.
Neuropsychology in Medical Environments: Implications for Managed Care. Successful Strategies for Surviving the Health Care Revolution Conference, Los Angeles, March 30, 1996.
Neurocognitive Examination in Traumatic Brain Injury: Forensic Considerations. The Combined Claims Conference, Queen Mary, Long Beach, CA, March 19, 1998.
Case Studies of Progressive Multifocal Leukoencephalopathy: Neurocognitive and Neuroradiological Findings. Seminar Presentation, UCLA Neuropsychiatric Institute, February 25, 1999.
Subjective Symptoms and Actual Findings: Subjective Thoughts on Actual Cases. Seminar Presentation: UCLA Neuropsychiatric Institute, April 13, 2000.
Brain Injury, Head Injury, No Injury: Assessing Neurocognitive Trauma. Continuing Legal Education (MCLE) Seminar, McClaugherty & Associates, Pasadena, May 5, 2000.
Neurocognitive Examination for Traumatic Brain Injury. Continuing Legal Education (MCLE) Seminar for Allstate Counsel, Indian Wells, August, 24, 2001.
Ginko Biloba, Quo Vadis? A seminar presentation and review of Gold, Cahill and Wenk (2002) Ginko Biloba: A Cognitive Enhancer? UCLA Neuropsychiatric Institute May 30, 2002.
Neurocognitive Examination for Traumatic Brain Injury. Continuing Legal Education (MCLE) Seminar, Zurawski & Chase, Orange, CA, October 18, 2002.
Neurocognitive Examination for Traumatic Brain Injury: with added Comments on Neurocognitive Factors in Aging. Continuing Legal Education (MCLE) Seminar, Eastern Bar Association, West Covina, CA, April 17, 2003.
Neurocognitive Examination for Traumatic Brain Injury, Continuing Legal Education (MCLE) Seminar, Bollington, Augustine & Chase, Brea, CA, February 25, 2004.
Questions and Answers on Neurocognitive Examination in Traumatic Brain Injury. Continuing Legal Education (MCLE) Seminar, Aker, Kowalik & Whipple, Los Angeles, July 15, 2004.
Occult Illness: Three Cases in Search of an Etiology.PSY 453 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, January 26, 2006.
Neurocognitive Self-Report: What Does it Mean? PSY 453 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, March 8, 2007.
Neurocognitive Symptoms in Somatoform Disorders: Theory, Differential, Cases. PSY 453 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, March 20, 2008.
Neurocognition: An Introduction. Continuing Legal Education (MCLE) Seminar, Offices of Bonnie R. Moss & Associates, Riverside, CA, March 31, 2009.
Neurocysticercosis: Pathology and Neurocognition. (with Aron Jacobson) PSY 453 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, February 25, 2010.
Major Neurological Illnesses Associated with HIV 1. PSY 447 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, October 18, 2012.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Offices of Craig G. Holtz, May 16, 2013.
Neurocysticercosis Update: Pathology and Neurocognition. (with Aron Jacobson)PSY 453 Post Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, October 14, 2013.
Occult Illness: Neurocognitive Findings. PSY 453 Post-Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, February 26, 2015.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Allstate Legal Department, Diamond Bar, CA, March 30, 2015.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, California Department of Transportation (CALTRANS) Legal Department, San Diego, CA, May 5, 2015.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, San Diego County Counsel’s Office, San Diego CA, May 20, 2015.
Post-Traumatic Stress Disorder: An Introduction. Continuing Legal Education (MCLE) Seminar, Riverside City Attorney’s Office, Riverside CA, May 13, 2016.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Tharpe & Howell, Sherman Oaks CA, September 20, 2016.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Austin, Brown, Wood, Cannon & Santa Cruz, San Diego CA, October 20, 2016.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Morris, Polich & Purdy, Los Angeles [with Remote to San Francisco], November 8, 2016.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar, Maranga – Morgenstern, Woodland Hills, January 12, 2017.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar. LaFollette Johnson DeHaas Fessler & Ames, Los Angeles, March 14, 2017.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar. Craig Holtz & Associates, Glendale, May 15, 2017.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar. Berman & Berman, Los Angeles, May 21, 2017.
Neurocognition and Injury: An Introduction. Continuing Legal Education (MCLE) Seminar. AAA Legal Department, Long Beach, August 28, 2017.
Neurocysticercosis Update: Pathology and Neurocognition. (with Aron Jacobson, M.A. & Christine You, Ph.D.) PSY 453 Post-Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, October 14, 2017.
Occult Illness II: Neurocognitive Findings. PSY 453 Post-Doctoral Seminar, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, UCLA, February 13, 2020.
PAPERS/POSTERS
Stenquist, P.K. (1985) The dual sex therapy team: An exploratory study, unpublished Master’s thesis. Southern Illinois University.
Hock, H.S., Rosenthal, A., and Stenquist, P.K. (1985) The category effect in visual search: Practice effects on catch trials, Perception and Psychophysics, 37, (1), 73-80.
Stenquist, P.K. (1987) Behavioral correlates of high and low scorers on the Mac Andrew Alcoholism Scale. Dissertation Abstracts International, 49, 3 B, 922.
Stenquist, P.K. (1989, August) Chronic psychogenic fatigue in Patients with Aids (PWAs), Being Alive, pp 12-13.
Stenquist, P.K. (1989, October) Avoiding probate: Protecting your patient’s interests with neuropsychology. LACMA Physician Journal of the Los Angeles County Medical Association, pp 46-47.
Aronow, H.A., Keith, P.K., Feraru, E.R., Cardona, L., Segfried, E., Beer, V., Faulk, A., Rodriguez, J. and Stenquist, P.K. (1990, June) Oral ketoconazole as prophylaxis for cryptococcal meningitis. The International Conference on Neurological and Neuropsychological Complications of HIV. Monterey.
Stenquist, P.K., Feraru, E.R., Aronow, H.A., van Gorp, W.G., Lawner, P. and Berger, J. (1990, June) Neuropsychological testing in progressive multifocal leukoencephalopathy (PML). The International Conference on Neurological and Neuropsychological Complications of HIV, Monterey.
Stenquist, P., Feraru, E.R. & van Gorp, W.G. (1991 November) Clinical neurocognitive improvement in AIDS Dementia with Zidovudine (AZT): A case study. Grand Rounds Symposium, XI Annual Conference of the National Academy of Neuropsychology, Dallas.
van Gorp, W.G., Marcotte, T. Hinkin, C. Stenquist, P., Mahler, M., Mitrushina, M. & Satz, P. (1992, November). Age as a risk factor for AIDS Dementia: Is there an interaction between age and serostatus? 45th Annual Scientific Meeting of the Gerontological Society of America, Washington.
van Gorp, W.G., Miller, E., Marcotte, T., Dixon, W., Paz, D., Selnes, O., Wesch J., Becker, J., Hinkin, C., Mitrushina, M., Satz, P., Weisman, J., & Stenquist, P. (1994). Relationship between age and cognitive impairment in HIV-1 Infection: Findings from the Multicenter Aids Cohort Study and a clinical cohort. Neurology, 44, 929-935.
Cherrier, M., Wood, S., Sultzer, D.L., Stenquist, P.K., Mendez, M., Mahler, M., Cumming, J.L., van Gorp, W.G., Hinkin, C., Pachana, N., & Moore, L. (1997) Neuropsychological performance of older AIDS, Alzheimer’s disease and healthy older controls. 77th Annual Conference of the Western Psychological Association, San Jose.
Kalechstein, A.D., Hinkin, C.H., Stenquist, P.K., van Gorp, W.G., Satz, P., Wood, S., Moore, L., & Pachana, N. (1997) Disease severity versus demographic characteristics as predictors of neuropsychological dysfunction in HIV patients. XXVth Annual Meeting of the International Neuropsychological Society, Orlando.
Castellon, S.A., Hardy, D.J., Stenquist, P.K., Hinkin, C.H., van Gorp, W.G., Moore, L., & Satz, P., (1999, February) Apathy and non-apathy items on the Beck Depression Inventory: Their neurocognitive correlates in HIV-1 infection. 27thAnnual Meeting of the International Neuropsychological Society, Boston.
Hardy, D.J., Hinkin, C.H., Stenquist, P.K., van Gorp, W.G., Satz, P., Wood, S. & Moore, L. (1999) Age differences and neurocognitive performance in HIV-infected adults, New Zealand Journal of Psychology, 28(2), 94-101.
Castellon, S. A., Hardy, D. J., Hinkin, C. H., Satz, P., Stenquist, P. K., van Gorp, W. V., & Meyers, H. F. (2006) Components of depression in HIV-1 Infection: The differential relationship to neurocognitive performance, Journal of Clinical and Experimental Neuropsychology, 28, 29-42.
Jacobson, A., & Stenquist, P. K. (2011, April) Apathy and executive performance in HIV-infected individuals, 91st Annual Conference of the Western Psychological Association, Los Angeles